Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 60.47%44.58K | -67.93%37.57K | -90.80%31.77K | -38.05%694.62K | -7.81%204.41K | -93.52%27.78K | -44.76%117.17K | 33.43%345.26K | -50.38%1.12M | -39.63%221.72K |
| Selling and administrative expenses | 40.77%39.11K | -67.19%37.57K | -86.64%37.77K | -33.14%344.04K | -162.17%-81.01K | -78.23%27.78K | -20.30%114.51K | 150.26%282.75K | -18.45%514.59K | -45.00%130.31K |
| -General and administrative expense | 40.77%39.11K | -67.19%37.57K | -86.64%37.77K | -33.14%344.04K | -162.17%-81.01K | -78.23%27.78K | -20.30%114.51K | 150.26%282.75K | -18.45%514.59K | -45.00%130.31K |
| Research and development costs | --0 | --0 | --0 | -95.30%1.5K | --0 | --0 | --0 | -71.94%1.5K | 409.56%31.94K | 1,272.21%8K |
| Other taxes | ---- | ---- | ---- | --9.5K | ---- | ---- | ---- | ---- | --0 | ---- |
| Other operating expenses | --5.47K | ---- | -109.83%-6K | -40.92%339.59K | 230.82%275.92K | ---- | -95.62%2.66K | -56.55%61.01K | -64.58%574.76K | -35.73%83.41K |
| Operating profit | -60.47%-44.58K | 67.93%-37.57K | 90.80%-31.77K | 38.05%-694.62K | 7.81%-204.41K | 93.52%-27.78K | 44.76%-117.17K | -33.43%-345.26K | 50.38%-1.12M | 39.63%-221.72K |
| Net non-operating interest income (expenses) | 66.56%-104 | 30.45%-153 | -25.82%-229 | 28.06%-1K | 5.90%-287 | 27.34%-311 | 49.66%-220 | 17.27%-182 | -52.58%-1.39K | -72.32%-305 |
| Total other finance cost | -66.56%104 | -30.45%153 | 25.82%229 | -28.06%1K | -5.90%287 | -27.34%311 | -49.66%220 | -17.27%182 | 52.58%1.39K | 72.32%305 |
| Other net income (expenses) | 3.86M | -94.03%414.54K | 214.90%21.84K | 6.14M | -789.66K | 6.95M | -19.01K | |||
| Gain on sale of security | --3.86M | --414.54K | --21.84K | ---655.14K | ---- | ---- | ---- | ---- | ---- | ---- |
| Special income (charges) | --0 | --0 | --0 | ---19.01K | --0 | --0 | --0 | ---19.01K | --0 | --0 |
| -Less:Other special charges | ---- | ---- | ---- | --19.01K | --0 | ---- | ---- | --19.01K | ---- | ---- |
| Other non-operating income (expenses) | ---- | ---- | ---- | --6.81M | ---134.52K | ---- | --6.95M | ---- | ---- | ---- |
| Income before tax | 13,695.42%3.82M | -94.48%376.82K | 97.21%-10.16K | 584.64%5.44M | -347.86%-994.36K | 93.45%-28.09K | 3,312.32%6.83M | -40.73%-364.45K | 43.89%-1.12M | 39.58%-222.02K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 13,695.42%3.82M | -94.48%376.82K | 97.21%-10.16K | 584.64%5.44M | -347.86%-994.36K | 93.45%-28.09K | 3,312.32%6.83M | -40.73%-364.45K | 43.89%-1.12M | 39.58%-222.02K |
| Net income continuous operations | 13,695.42%3.82M | -94.48%376.82K | 97.21%-10.16K | 584.64%5.44M | -347.86%-994.36K | 93.45%-28.09K | 3,312.32%6.83M | -40.73%-364.45K | 43.89%-1.12M | 39.58%-222.02K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 13,695.42%3.82M | -94.48%376.82K | 97.21%-10.16K | 584.64%5.44M | -347.86%-994.36K | 93.45%-28.09K | 3,312.32%6.83M | -40.73%-364.45K | 43.89%-1.12M | 39.58%-222.02K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 13,695.42%3.82M | -94.48%376.82K | 97.21%-10.16K | 584.64%5.44M | -347.86%-994.36K | 93.45%-28.09K | 3,312.32%6.83M | -40.73%-364.45K | 43.89%-1.12M | 39.58%-222.02K |
| Diluted earnings per share | 0.06 | -91.67%0.01 | 0 | 550.00%0.09 | -0.02 | 0 | 2,796.02%0.12 | 0.00%-0.01 | 60.00%-0.02 | 0 |
| Basic earnings per share | 0.06 | -91.67%0.01 | 0 | 550.00%0.09 | -0.02 | 0 | 2,796.02%0.12 | 0.00%-0.01 | 60.00%-0.02 | 0 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.